Ultralife Corporation (ULBI) is a publicly traded Industrials sector company. As of May 21, 2026, ULBI trades at $6.12 with a market cap of $101.61M and a P/E ratio of -0.15. ULBI moved +0.17% today. Year to date, ULBI is +0.17%; over the trailing twelve months it is +7.73%. Its 52-week range spans $4.07 to $10.09. Rallies surfaces ULBI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ULBI financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ULBI recently traded at $6.12. Market cap is $101.61M. P/E ratio is -0.15. Revenue is $187.86M.
| Metric | Value |
|---|---|
| Price | $6.12 |
| Market Cap | $101.61M |
| P/E Ratio | -0.15 |
| EPS | $-38.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.09 |
| 52-Week Low | $4.07 |
| Volume | 106 |
| Avg Volume | 0 |
| Revenue (TTM) | $187.86M |
| Net Income | $-8.30M |
| Gross Margin | 23.09% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $191.16M | $-5.95M | $-35.00 |
| 2024 | $164.46M | $6.41M | $0.38 |
| 2023 | $158.64M | $7.17M | $0.03 |
| 2022 | $131.84M | $-120.00K | $0.03 |
ULBI analyst coverage data. Average price target: $0.00.